Screener
Stryker SYK Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $6.59B+9.4% | $6.02B+2.6% | $7.17B+11.4% | $6.06B+10.2% | $6.02B+11.1% | ||
| $2.09B-4.1% | $2.21B+4.1% | $2.54B+12.4% | $2.21B+11.5% | $2.18B+8.7% | ||
| $4.5B+17.1% | $3.81B+1.8% | $4.63B+10.9% | $3.85B+9.5% | $3.84B+12.4% | ||
| 68.3%+4.5pp | 63.3%-0.5pp | 64.5%-0.3pp | 63.6%-0.4pp | 63.8%+0.8pp | ||
| $434M+6.6% | $413M+2.0% | $401M+12.0% | $410M+8.8% | $407M+12.1% | ||
| $2.23B+7.2% | $2.28B-0.8% | $2.23B+4.9% | $2.05B+8.0% | $2.08B+13.5% | ||
| $2.84B+4.1% | $2.87B-1.1% | $2.82B-21.4% | $2.72B+11.7% | $2.73B+15.3% | ||
| $1.66B+49.1% | $936M+11.8% | $1.8B+210% | $1.14B+4.6% | $1.11B+5.9% | ||
| 25.2%+6.7pp | 15.5%+1.3pp | 25.2%+16.1pp | 18.7%-1.0pp | 18.5%-0.9pp | ||
| —— | $148M+8.0% | —— | —— | —— | ||
| -$95M+2.1% | $62M-3.1% | $508M+42.7% | -$106M-152% | -$97M-83.0% | ||
| $1.56B+53.9% | $850M+11.3% | $1.71B+223% | $1.03B-1.3% | $1.02B+1.8% | ||
| $288M+118% | $105M-4.5% | $856M— | $170M-18.7% | $132M-23.7% | ||
| $1.28B+44.3% | $745M+13.9% | $849M+55.5% | $859M+3.0% | $884M+7.2% | ||
| 19.4%+4.7pp | 12.4%+1.2pp | 11.8%+3.4pp | 14.2%-1.0pp | 14.7%-0.5pp | ||
| $3.30+44.1% | $1.93+14.2% | $2.20+56.0% | $2.22+2.8% | $2.29+7.0% | ||
| $1.66B+49.1% | $936M+11.8% | $1.8B+210% | $1.14B+4.6% | $1.11B+5.9% |
FAQ
- What is Stryker's revenue?
- Stryker (SYK) generated $25.8B in revenue over the trailing twelve months, up 8.5% year over year.
- Is Stryker profitable?
- Stryker reported $3.7B in net income over the trailing twelve months, a 14.4% net margin.
- What are Stryker's profit margins?
- Gross margin is 65.0% and operating margin is 21.4%, with a 14.4% net margin.
- What is Stryker's earnings per share?
- Stryker's diluted EPS over the trailing twelve months is $9.65.
- Where does Stryker's income statement data come from?
- Every line is extracted from Stryker's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
